SCHEMBL7198142

SCHEMBL7198142

CC=Cc1cncc2ccccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 2/20 0.44
KDR P35968 2/20 0.44
ERBB2 P04626 1/20 0.44
CYP11B2 P19099 3/20 0.40
CYP11B1 P15538 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2B6 P20813 1/20 0.40
CYP2C19 P33261 1/20 0.40
PRKCZ Q05513 1/20 0.40
ADRA2A P08913 1/20 0.39
ADRA2B P18089 1/20 0.39
ADRA2C P18825 1/20 0.39
ADRA1A P35348 1/20 0.39
CHAT P28329 4/20 0.38
HTT P42858 1/20 0.37
SRD5A1 P18405 1/20 0.37
SRD5A2 P31213 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3103592 0.81 AURKA (0.44) AURKAKDRERBB2CYP11B2CYP11B1
SCHEMBL3164183 0.81 GRM4 (0.47) AURKAKDRERBB2CYP11B2CYP11B1
SCHEMBL3103597 0.81 AURKA (0.44) AURKAKDRERBB2CYP11B2CYP11B1
SCHEMBL3164179 0.81 GRM4 (0.47) AURKAKDRERBB2CYP11B2CYP11B1
SCHEMBL18387869 0.80 AURKA (0.41) AURKAKDRERBB2CYP11B2CYP11B1
SCHEMBL6655162 0.78 AURKA (0.45) AURKAKDRERBB2CYP11B2CYP11B1
SCHEMBL6655165 0.78 AURKA (0.45) AURKAKDRERBB2CYP11B2CYP11B1
SCHEMBL11882678 0.78 HTT (0.54) CYP11B2CYP11B1CYP1A2CYP3A4CYP2D6
SCHEMBL13181041 0.78 TLR8 (0.49) AURKAKDRERBB2CYP11B2CYP11B1
SCHEMBL6879468 0.77 AURKA (0.41) AURKAKDRERBB2CYP11B2CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6590083-B1 Compounds of given formula; erythromycin derivatives; useful in the treatment of bacterial and protozoal infections and conditions involving gastric motility ORTHO-MCNEIL PHARMACEUTICAL, INC. 2003-07-08 US disclosed